Key Players
Competitive Landscape
As noted by FMI, competition in the personalized nutrition sector divides between multinational ingredient and medical-nutrition suppliers, multi-omic diagnostic AI platforms, and direct-to-consumer custom supplement formulators. DSM-Firmenich AG and Nestlé Health Science S.A. supply patented vitamin premixes, human milk oligosaccharides, and GLP-1 companion proteins, whereas ZOE Limited, Viome Life Sciences, Inc., and Segterra, Inc. operate proprietary gut-microbiome and blood-biomarker recommendation engines. Thorne HealthTech, Inc., Gainful Health Inc., and Baze Labs scale automated 30-day sachet and custom powder subscriptions.
Since early 2025 and continuing through mid-2026, strategic investment has shifted from static DNA cheek-swab kits toward longitudinal blood-biomarker tracking, over-the-counter continuous glucose telemetry, and GLP-1 lean-muscle preservation stacks. Formulators are replacing generic pill packs with high-bioavailability microgel shakes, pectin gummies, and precision synbiotic sachets calibrated to 90-day retest panels. Platforms that link diagnostic retesting directly to automated formula adjustments capture superior 12-month subscriber retention.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| August 2026: Thorne HealthTech released clinical consumer research on its Creatine plus Alpha-GPC performance formulation [21]. | Athletes and active adults demand NSF Certified for Sport personalized recovery and amino acid stacks. | D2C platforms pair at-home blood and microbiome testing with daily single-serve powder and capsule packs. | Bundled quarterly biomarker retesting locks in recurring 12-month athlete subscription retention. |
| July 2025: Point-of-care metabolic biosensor investigators validated a smartphone-connected blood and saliva ketone sensor for precision nutrition [13]. | Longevity consumers require objective blood-panel proof that custom supplement regimens improve lipid and inflammatory markers. | Platforms integrate 40+ blood biomarkers with wearable heart-rate-variability and sleep telemetry. | B2B2C licensing of biomarker recommendation engines to longevity clinics and corporate wellness plans expands margin. |
| February 2026: dsm-firmenich detailed its Health, Nutrition & Care precision microbiome and medical nutrition research in its 2025 Annual Report [19]. | Supplement brands require clinically validated human milk oligosaccharides, postbiotics, and microencapsulated vitamins. | Ingredient suppliers formulate compression-stable custom premixes and targeted gut-barrier synbiotics. | Turnkey white-label personalized sachet and gummy manufacturing accelerates D2C brand launches. |
| February 2026: Nestle S.A. integrated Nutrition and Nestle Health Science to scale GLP-1 companion and active personalized nutrition [20]. | Patients on incretin weight-loss therapies experience lean muscle loss and micronutrient deficits. | Nutrition leaders launch high-whey microgel shakes, collagen peptides, and prebiotic fiber companions. | Clinician-recommended GLP-1 muscle-preservation subscription bundles capture high-value pharmacy and D2C orders. |
Source: Future Market Insights, Personalized Nutrition Market Report, 2026-2036.
DSM-Firmenich AG and Nestlé Health Science S.A. anchor global bioactive ingredient and GLP-1 companion supply, while ZOE Limited, Viome Life Sciences, Inc., and Segterra, Inc. lead multi-omic diagnostic scoring. Thorne HealthTech, Inc., Gainful Health Inc., and Baze Labs convert biomarker readouts into recurring custom supplement subscriptions.
How are key market participants positioned in the personalized nutrition market?
DSM-Firmenich AG and Nestlé Health Science S.A. provide B2B precision premixes, probiotics, and medical nutrition brands. ZOE Limited, Viome Life Sciences, Inc., and Segterra, Inc. operate diagnostic-led subscription apps, while Thorne HealthTech, Inc., Gainful Health Inc., and Baze Labs specialize in custom-dosed supplements and sports powders.
What qualification or purchasing requirements matter most to prospective buyers?
Longevity clinics and D2C subscribers require CLIA- and CAP-certified laboratory accuracy for dried-blood-spot and shotgun metagenomic assays with NSF Certified for Sport or USP-verified supplement purity. B2B2C corporate wellness buyers prioritize HIPAA- and GDPR-compliant biomarker dashboards and published randomized clinical trial proof.
Which product or application capabilities distinguish the leading companies?
Diagnostic platforms differentiate through proprietary machine-learning models trained on hundreds of thousands of postprandial glucose, blood-fat, and metatranscriptomic RNA profiles. Supplement manufacturers compete on automated single-sachet robotic dispensing, flavor-masked peptide microgels, and stability-tested synbiotic combinations.
How does geographic reach differ among the key market players?
DSM-Firmenich AG and Nestlé Health Science S.A. operate global formulation and distribution networks across North America, Europe, Asia-Pacific, Latin America, and the Middle East. Thorne HealthTech, Inc., ZOE Limited, Viome Life Sciences, Inc., Segterra, Inc., Gainful Health Inc., and Baze Labs focus primary D2C subscription fulfillment across the United States, the United Kingdom, Canada, and Western Europe.
Representative Company Overview
| Company | Positioning | Verified Development |
|---|---|---|
| DSM-Firmenich AG | Global nutritional ingredients, custom vitamin premix, and precision gut-microbiome formulator. | Published 2025 Integrated Annual Report research milestones on precision microbiome nutrition in February 2026 [19]. |
| Nestlé Health Science S.A. | Global leader in medical nutrition, active protein supplementation, and GLP-1 companion formulations. | Launched its dedicated glp-1nutrition.com companion platform for muscle preservation and gut health [22]. |
| Thorne HealthTech, Inc. | Science-backed personalized supplement and at-home blood and gut-health testing platform. | Published clinical research on Creatine plus Alpha-GPC for physical and cognitive performance in August 2026 [21]. |
| ZOE Limited | UK- and US-based cardiometabolic and gut-microbiome testing and personalized nutrition membership provider. | Published peer-reviewed research on precision nutrition pathways in 2026[14]. |
| Viome Life Sciences, Inc. | Metatranscriptomic RNA sequencing and custom-compounded precision probiotic and supplement formulator. | Validated shotgun metagenomic and metatranscriptomic glycemic prediction pathways in August 2026 [17]. |
| Segterra, Inc. | Operator of the InsideTracker blood-biomarker, DNA, and wearable telemetry longevity platform. | Released longitudinal clinical data confirming sustained member biomarker improvements in May 2026 [7]. |
| Gainful Health Inc. | Direct-to-consumer personalized protein powder, hydration, pre-workout, and performance supplement brand. | Expanded algorithmic hydration and amino-acid customization for lean muscle preservation in 2026 [23]. |
| Baze Labs (Nature's Way) | Blood-biomarker-guided personalized daily vitamin packet and painless capillary blood-collection specialist. | Advanced SNP and capillary blood micronutrient dosing protocols across personalized packs in August 2026 [18]. |
Research Methodology
The personalized nutrition market assessment was conducted using a combination of primary research, secondary research, and data triangulation to validate market size, segmentation shares, country-level growth rates, and competitive positioning from 2026 to 2036. Secondary research reviewed corporate annual reports, peer-reviewed clinical trials on CGM-guided and microbiome-personalized diets in JMIR, Nutrients, and Diabetes Care, and national regulatory sandboxes. Primary interviews engaged D2C supplement executives, longevity clinic directors, and premix formulators to reconcile top-down expenditure models against bottom-up active subscriber cohorts and quarterly retest volumes.
